4Tuszynski MH,Smith DE,Roberts J,et al.Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloidplaque deposition.Exp Neurol,1998,154 (2):573-582.
8Raskind MA,Peskind ER,Truyen L,et al.The cognitive benefits of galantamine are sustained for at least 36 months:a longterm extension trial.Arch Neurol,2004,61 (2):252-256.
9Peacock JM,Folsom AR,Knopman DS,et al.Association of nonsteroidal antiinflammatory drugs and aspirin with cognitive performance in middle aged adults.Neuro epidemiology,1999,18 (3):134-143.
4[3]Chen KS,Gage FH.Somatic gene transfer of NGF to the aged brain:behavioral and morphological melioration[J].J Neurosci,1999,15(4):2819-25
5[4]Tusvynski MH,Roberts J,Senut MC,et al.Gene therapy in the adult primate brain:intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neu ronal degeneration[J].Gene Ther.1999,3(4):305-14
6[5]Blesch A,Conner JM,Tusvynski MH,et al.Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neu rotrophin expression[J].Gene Ther,2001,8(12):954-60
7[8]Gastel B,Jazat PF,Barneud P,et al.Intracerebral nerve growth factor gene transfer using a recombinant adenovirus:effect on basal forebrain cholinergic neurons during aging[J].Neurobi Dis,1999,3(1):176-86
8[9]Zou LL,Huang L,Hayes RE et al.Liposome mediated NGF gene transfection following neuronal injury potential therapeutic applica tions[J].Gene Ther,1999,6(6):994-1005.
9[10]Klein RL.NGF gene transfer to intrinsic basal forebrain neuron s increases cholingic cell size and protects from aged related,spat ial memory deficits in middle aged rats[J].Brain Res,2000,875(1-2):144-151.
10Haring R, Fisher A, Marciano D, et al. Mitogen- activated protein kinase- dependent and protein kinase C- dependent pathways link the M1 muscarinic receptor to beta- amyloid precursor protein secretion. J Neurochem, 1998,71(5):2094~ 2103.